The 5 analysts offering 1 year price forecasts for EGTX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to EGTX in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
EGTX EPS for the last quarter is −0.28 SEK despite the estimation of −0.30 SEK. In the next quarter EPS is expected to reach −0.26 SEK. Track more of EGETIS THERAPEUTICS AB financials and stay on top of what is up with the company.
According to analysts, EGTX price target is 12.50 SEK with a max estimate of 14.50 SEK and a min estimate of 10.00 SEK. Check if this forecast comes true in a year, meanwhile watch EGETIS THERAPEUTICS AB stock price chart and keep track of the current situation with EGTX news and stock market news.
We've gathered opinions of 5 analysts rating EGTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.